发明授权
![Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase](/docs/US/2014-09-02/US08822469B2/abs.jpg.600x600.jpg)
- 专利标题： Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
- 专利标题（中）： 吡咯并[2,3-B]吡嗪可用作ATR激酶的抑制剂
-
申请号： US13531461申请日： 2012-06-22
-
公开(公告)号： US08822469B2公开(公告)日： 2014-09-02
- 发明人: Somhairle MacCormick , Pierre-Henri Storck , Michael Paul Mortimore , Jean-Damien Charrier , Ronald Knegtel , Stephen Clinton Young , Joanne Pinder , Steven John Durrant
- 申请人： Somhairle MacCormick , Pierre-Henri Storck , Michael Paul Mortimore , Jean-Damien Charrier , Ronald Knegtel , Stephen Clinton Young , Joanne Pinder , Steven John Durrant
- 申请人地址： US MA Boston
- 专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人地址： US MA Boston
- 代理商 Jennifer G. Che
- 主分类号： A61K31/4985
- IPC分类号： A61K31/4985 ; C07D241/36
![Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase](/abs-image/US/2014/09/02/US08822469B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to pyrrolopyrazines compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.The compounds of this invention have formula I: wherein the variables are as defined herein.
公开/授权文献
- US20130018035A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE 公开/授权日：2013-01-17